Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Feb;10(2):264-70.
doi: 10.1023/a:1018947113238.

Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model

Affiliations
Free article

Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model

D M Oh et al. Pharm Res. 1993 Feb.
Free article

Abstract

A microscopic mass balance approach has been developed to predict the fraction dose absorbed of suspensions of poorly soluble compounds. The mathematical model includes four fundamental dimensionless parameters to estimate the fraction dose absorbed: initial saturation (Is), absorption number (An), dose number (Do), and dissolution number (Dn). The fraction dose absorbed (F) increases with increasing Is, An, and Dn and with decreasing Do. At higher Dn and lower Do, the fraction dose absorbed reaches the maximal F, which depends only on An. The dissolution number limit on F can appear at both lower Do and lower Dn. Likewise, at higher Do and Dn, the fraction dose absorbed reaches a Do limit. Initial saturation makes a significant difference in F at lower Do and Dn. It is shown that the extent of drug absorption is expected to be highly variable when Dn and Do are approximately one. Furthermore, by calculating these dimensionless groups for a given compound, a formulation scientist can estimate not only the extent of drug absorption but also the effect, if any, of particle size reduction on the extent of drug absorption.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Pharm Res. 1991 Aug;8(8):979-88 - PubMed
    1. J Pharm Sci. 1963 Jan;52:67-71 - PubMed
    1. J Clin Hosp Pharm. 1981 Jun;6(2):117-33 - PubMed
    1. J Pharm Sci. 1986 Feb;75(2):109-16 - PubMed
    1. Pharm Res. 1988 Oct;5(10):651-4 - PubMed

Publication types